Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Int J Neuropsychopharmacol ; 20(1): 58-66, 2017 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-27638901

RESUMO

Background: The effects of acute tryptophan depletion on human decision-making suggest that serotonin modulates the processing of rewards and punishments. However, few studies have assessed which of the many types of serotonin receptors are responsible. Methods: Using a within-subject, double-blind, sham-controlled design in 26 subjects, we examined whether individual differences in serotonin system gene transcription, measured in peripheral blood, predicted the effect of acute tryptophan depletion on decision-making. Participants performed a task in which they chose between successive pairs of fixed, lower-stakes (control) and variable, higher-stakes (experimental) gambles, each involving wins or losses. In 21 participants, mRNA from 9 serotonin system genes was measured in whole blood prior to acute tryptophan depletion: 5-HT1B, 5-HT1F, 5-HT2A, 5-HT2B, 5-HT3A, 5-HT3E, 5-HT7 (serotonin receptors), 5-HTT (the serotonin transporter), and tryptophan hydroxylase 1. Results: Acute tryptophan depletion did not significantly influence participants' sensitivity to probability, wins, or losses, although there was a trend for a lower tendency to choose experimental gambles overall following depletion. Significant positive correlations, which survived correction for multiple comparisons, were detected between baseline 5-HT1B mRNA levels and acute tryptophan depletion-induced increases in both the overall tendency to choose the experimental gamble and sensitivity to wins. No significant relationship was observed with any other peripheral serotonin system markers. Computational analyses of decision-making data provided results consistent with these findings. Conclusions: These results suggest that the 5-HT1B receptor may modulate the effects of acute tryptophan depletion on risky decision-making. Peripheral levels of serotonin markers may predict response to treatments that act upon the serotonin system, such as selective serotonin reuptake inhibitors.


Assuntos
Tomada de Decisões/fisiologia , Jogo de Azar/sangue , Receptor 5-HT1B de Serotonina/sangue , Triptofano/deficiência , Adulto , Ansiedade/sangue , Método Duplo-Cego , Feminino , Humanos , Masculino , Testes Neuropsicológicos , RNA Mensageiro/sangue , Tempo de Reação/fisiologia , Caracteres Sexuais , Triptofano/sangue
2.
J Headache Pain ; 16: 71, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26242873

RESUMO

BACKGROUND: In this study, we retrospectively analyzed the relationship between headache recurrence and serotonin 5-HT1B/1D receptor occupancy (Φ1B and Φ1D). Triptans marketed in Japan (sumatriptan, zolmitriptan, eletriptan, rizatriptan, naratriptan) were investigated. METHODS: Receptor occupancies were calculated from both the pharmacokinetic and pharmacodynamic data of triptans. We examined the relationships between recurrence rate and elimination half-lives, and Ф1B and Ф1D, as calculated from the time-course of plasma drug concentration obtained from other studies. The time until Ф1B and Ф1D became 50% or less, 40% or less, and 30% or less was calculated as duration time to examine the relationship with recurrence rate. RESULTS: For Ф1B, eletriptan remained at a low level. For Ф1D, it was indicated that all triptans obtained an occupancy of 80% or higher at maximum. For all items, though recurrence tended to be lower along with longer half-life, no significant statistical correlation was found. For both Ф1B and Ф1D, the recurrence rate tended to be lower as the duration became longer. In addition, a significant correlation was observed for Ф1D (p < 0.05). For clarifying the Ф value and time period most closely correlated with recurrence rate, recurrence and Ф1B and Ф1D at 6, 12, and 18 h after administration were calculated. The most significant correlation was observed between recurrence rate and Ф1D at 12 h after administration (p < 0.01). CONCLUSIONS: As an index for evaluating headache recurrence following triptan administration, recurrence rate and Ф1D value at 12 h after administration were found to be most closely correlated and useful for analysis. Our results indicate that headache recurrence inhibition can be evaluated using these values.


Assuntos
Transtornos de Enxaqueca/sangue , Transtornos de Enxaqueca/tratamento farmacológico , Receptor 5-HT1B de Serotonina/sangue , Receptor 5-HT1D de Serotonina/sangue , Agonistas do Receptor de Serotonina/sangue , Triptaminas/sangue , Idoso , Feminino , Cefaleia/sangue , Cefaleia/tratamento farmacológico , Cefaleia/epidemiologia , Humanos , Japão/epidemiologia , Masculino , Pessoa de Meia-Idade , Transtornos de Enxaqueca/epidemiologia , Recidiva , Estudos Retrospectivos , Agonistas do Receptor de Serotonina/uso terapêutico , Triptaminas/uso terapêutico
3.
Neurosci Lett ; 382(1-2): 1-4, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15885906

RESUMO

Serotonin (5-HT) is a neurotransmitter and an immune modulator. At the periphery, the serotonergic system appears to possess a regulatory activity via 5-HT 1B receptors. The present study investigated the effects of a 5-day military course following 3 weeks of combat training on the functional activity of 5-HT 1B/1D receptors in peripheral blood lymphocytes of male soldiers. The results of [35S]GTPgammaS binding assays showed that h5-HT 1B/1D receptors were desensitized after the training program, although serum 5-HT was unchanged. These data suggest the existence of a control on T cells mediated through h5-HT 1B/1D receptors leading cytokine production modulation after a physical training.


Assuntos
Aptidão Física/fisiologia , Receptor 5-HT1B de Serotonina/sangue , Linfócitos T/metabolismo , Linfócitos T/fisiologia , Adulto , Limiar Anaeróbio/fisiologia , Membrana Celular/química , Membrana Celular/metabolismo , Citocinas/biossíntese , Guanosina 5'-O-(3-Tiotrifosfato) , Humanos , Masculino , Militares , Neuropeptídeos/metabolismo , Oligopeptídeos/metabolismo , Serotonina/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA